Sichuan Saizhuo Pharmaceutical

Sichuan Saizhuo Pharmaceutical is a pharmaceutical company based in Mianyang, Sichuan, China, specializing in the development and manufacture of chemical APIs and finished dosage forms. Founded in 2007 and a subsidiary of the Hengkang Group, the company is listed on the National Equities Exchange and Quotations (NEEQ). Its core business focuses on anti-infective medications, particularly third-generation cephalosporins like Cefixime and Cefdinir. Additionally, the company is advancing a pipeline of generic and innovative drugs, including the Class 1.1 antibiotic Litazolidone and treatments for cardiovascular and urological conditions. The company operates GMP-certified manufacturing facilities for solid oral preparations and powder injections, serving the domestic Chinese market.